Mangiferin attenuates osteoclastogenesis, bone resorption, and RANKL-induced activation of NF-κB and ERK.
about
Sinomenine suppresses osteoclast formation and Mycobacterium tuberculosis H37Ra-induced bone loss by modulating RANKL signaling pathwaysInhibitory Effects of KP-A159, a Thiazolopyridine Derivative, on Osteoclast Differentiation, Function, and Inflammatory Bone Loss via Suppression of RANKL-Induced MAP Kinase Signaling PathwayMangiferin: a natural miracle bioactive compound against lifestyle related disorders.The study of mechanisms of protective effect of Rg1 against arthritis by inhibiting osteoclast differentiation and maturation in CIA miceMangiferin reduces the inhibition of chondrogenic differentiation by IL-1β in mesenchymal stem cells from subchondral bone and targets multiple aspects of the Smad and SOX9 pathwaysMangiferin has an additive effect on the apoptotic properties of hesperidin in Cyclopia sp. tea extracts.Chlamydial plasmid-encoded virulence factor Pgp3 neutralizes the antichlamydial activity of human cathelicidin LL-37.Commercial Honeybush (Cyclopia spp.) Tea Extract Inhibits Osteoclast Formation and Bone Resorption in RAW264.7 Murine Macrophages-An in vitro Study.Andrographolide Inhibits Ovariectomy-Induced Bone Loss via the Suppression of RANKL Signaling Pathways.Kinsenoside prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis by regulating classical NF-κB pathways.Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer modelNitidine chloride prevents OVX-induced bone loss via suppressing NFATc1-mediated osteoclast differentiation.TREM-2 promotes acquired cholesteatoma-induced bone destruction by modulating TLR4 signaling pathway and osteoclasts activation.Combination of IL-6 and sIL-6R differentially regulate varying levels of RANKL-induced osteoclastogenesis through NF-κB, ERK and JNK signaling pathways.Andrographolide prevents human breast cancer-induced osteoclastic bone loss via attenuated RANKL signaling.Paclitaxel inhibits osteoclast formation and bone resorption via influencing mitotic cell cycle arrest and RANKL-induced activation of NF-κB and ERK.Naringin abrogates osteoclastogenesis and bone resorption via the inhibition of RANKL-induced NF-κB and ERK activation.Eriodictyol Inhibits RANKL-Induced Osteoclast Formation and Function Via Inhibition of NFATc1 Activity.Inhibition of RANKL-dependent cellular fusion in pre-osteoclasts by amiloride and a NHE10-specific monoclonal antibody.Mangiferin positively regulates osteoblast differentiation and suppresses osteoclast differentiation.Potential role of rebamipide in osteoclast differentiation and mandibular condylar cartilage homeostasis.Cyanidin Chloride inhibits ovariectomy-induced osteoporosis by suppressing RANKL-mediated osteoclastogenesis and associated signaling pathways.Dual Role of Cyanidin-3-glucoside on the Differentiation of Bone Cells.Mangiferin inhibits apoptosis and oxidative stress via BMP2/Smad-1 signaling in dexamethasone-induced MC3T3-E1 cells.In vitro studies on mangiferin protection against cadmium-induced human renal endothelial damage and cell death via the MAP kinase and NF-κB pathways.Therapeutic and Preventive Effects of Osteoclastogenesis Inhibitory Factor on Osteolysis, Proliferation of Mammary Tumor Cell and Induction of Cancer Stem Cells in the Bone Microenvironment.Transcriptional activation of glucose transporter 1 in orthodontic tooth movement-associated mechanical response
P2860
Q28533497-7A00E51F-09E8-416B-B60A-4ADBB1A3E8A4Q28550685-3FC25305-21E1-4448-B022-44D97CF7066CQ33630122-E833858F-FD8A-487C-AE4E-5830B6791046Q34152121-52E9F765-39E5-46A3-AB28-BAF808577277Q34359063-D6A177CC-5CD2-4548-A3D7-99583946C488Q35122053-DD6DFBC4-426C-4635-AFDF-450723C51458Q36281321-50959492-42D9-4308-90BF-8C41B1AAFA77Q36323973-65B670E2-9B95-4C16-8F61-927CC2168116Q36324729-0AF8C8F9-5F66-442E-9734-F6F5ED028B99Q36770410-321B9F3A-0259-4843-94AF-534A894CC952Q36847530-DAD40CF0-AA19-4EEE-BD3B-B8DBC1001653Q37399717-3CF8A6B0-60D1-4C35-BF7B-3C4EDCCBDF64Q37488152-58CA8519-74CA-4CCC-898A-B741087D8811Q37609556-07A2D7C5-4296-4A61-B347-EA3A6CC7ABBCQ39028702-AC599976-0EA9-4AA3-96F8-4EA154BE21EAQ39451512-470846F2-D426-4949-BBC5-A7735F367F46Q39491637-B88C0415-4B0B-481D-A9A3-26674F844661Q40120415-11C28235-2B93-4E2F-9655-A53B86B5779AQ41527923-25CC4221-BFF8-46D3-A4CF-A80532CAB38FQ42347146-CE2021AE-48B4-4A7D-85E1-4229BC0D62F2Q47632345-A8F4505F-AD08-4584-8F04-F0745E57098BQ47995224-DF88CB18-E7E9-45EE-A508-D49AF4549A00Q50437421-BB77BE91-E4CE-4E7B-B2C7-FB94F3497B07Q52684048-CCBDDE87-63A1-428C-BDB7-DD5063A04194Q53573867-C75B4563-10ED-4A02-B183-DDB2672174A0Q55117611-2E833D31-54F5-4A10-B10C-F2BD4D18F052Q58778474-E7F1C248-D859-4F1E-95B9-F958F68E79C3
P2860
Mangiferin attenuates osteoclastogenesis, bone resorption, and RANKL-induced activation of NF-κB and ERK.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Mangiferin attenuates osteocla ...... d activation of NF-κB and ERK.
@en
Mangiferin attenuates osteocla ...... d activation of NF-κB and ERK.
@nl
type
label
Mangiferin attenuates osteocla ...... d activation of NF-κB and ERK.
@en
Mangiferin attenuates osteocla ...... d activation of NF-κB and ERK.
@nl
prefLabel
Mangiferin attenuates osteocla ...... d activation of NF-κB and ERK.
@en
Mangiferin attenuates osteocla ...... d activation of NF-κB and ERK.
@nl
P2093
P2860
P356
P1476
Mangiferin attenuates osteocla ...... d activation of NF-κB and ERK.
@en
P2093
Estabelle Ang
Honghui Chen
Ming H Zheng
Xiaohong Yang
P2860
P356
10.1002/JCB.22800
P577
2011-01-01T00:00:00Z